ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
7.94
-0.29 (-3.52%)
At close: May 22, 2026, 4:00 PM EDT
8.07
+0.13 (1.64%)
After-hours: May 22, 2026, 7:19 PM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $788.47 million as of May 22, 2026. Its market cap has decreased by -40.49% in one year.
Market Cap
788.47M
Enterprise Value
758.69M
1-Year Change
-40.49%
Ranking
Category
Stock Price
$7.94
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $788.47M, an increase of 38.75%. That is a compound annual growth rate of 9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 788.47M | -31.53% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 829.42M |
| Odyssey Therapeutics | 825.55M |
| Bright Minds Biosciences | 825.09M |
| Evommune | 823.74M |
| Geron | 821.15M |
| CytomX Therapeutics | 818.56M |
| LB Pharmaceuticals | 806.39M |
| Avalo Therapeutics | 802.07M |